key: cord-0999280-d1nugnpk
authors: Kawada, Tomoyuki
title: Letter regarding “Non-aneurysmal subarachnoid hemorrhage in patients with COVID-19”
date: 2021-03-30
journal: Neuroradiology
DOI: 10.1007/s00234-021-02700-3
sha: bf0811a6193c921c0469e2449083b22d4c5cabae
doc_id: 999280
cord_uid: d1nugnpk

nan

Dear Editor: Coronavirus disease 2019 (COVID-19) is associated with hyper-coagulopathy, and appropriate anticoagulant therapy is needed to improve the condition of patients with venous thromboembolism. Spontaneous intracranial hemorrhage, including non-aneurysmal subarachnoid hemorrhage (SAH), occurs in patients with severe COVID-19. Harrogate et al. reported two such cases in patients with severe COVID-19 [1] and recommended careful observations for detecting non-aneurysmal SAH in patients with anticoagulant therapy. I present information regarding case reports in COVID-19 patients with non-aneurysmal SAH with special reference to anticoagulant therapy.

Batcik et al. reported cases of four patients with COVID-19 who experienced spontaneous non-aneurysmal SAH, which was observed in the early and late stages of COVID-19 infection [2] . They recognized two cases with anticoagulant therapy. Altschul et al. reported two cases of COVID-19 patients with SAH, and one case received anticoagulant therapy [3] . Given that disseminated intravascular coagulopathy and severe bleeding events are uncommon in patients in any stage of COVID-19 infection [4] , anticoagulant therapy should be evaluated by multivariate analysis to determine whether it is a major risk factor for non-aneurysmal SAH.

Some triggers might exist in patients with COVID-19 and SAH in relation to host immune responses and immunerelated symptoms [5] . Regardless, preventing nonaneurysmal SAH in patients with COVID-19 is important and should be explored in further studies.

Conflict of interest I declare that I have no conflict of interest.

Informed consent NA

Non-aneurysmal subarachnoid haemorrhage in COVID-19

COVID-19 infection produces subarachnoid hemorrhage; acting now to understand its cause: a short communication

Hemorrhagic presentations of COVID-19: risk factors for mortality

The impact of COVID-19 disease on platelets and coagulation

Cytokine storm